serw-MX  [xml]  
 
    
 DeCS Categories

C09 Otorhinolaryngologic Diseases .
C09.218 Ear Diseases .
C09.218.458 Hearing Disorders .
C09.218.458.341 Hearing Loss .
C09.218.458.341.186 Deafness .
C10 Nervous System Diseases .
C10.597 Neurologic Manifestations .
C10.597.751 Sensation Disorders .
C10.597.751.418 Hearing Disorders .
C10.597.751.418.341 Hearing Loss .
C10.597.751.418.341.186 Deafness .
C23 Pathological Conditions, Signs and Symptoms .
C23.550 Pathologic Processes .
C23.550.260 Death .
C23.888 Signs and Symptoms .
C23.888.592 Neurologic Manifestations .
C23.888.592.763 Sensation Disorders .
C23.888.592.763.393 Hearing Disorders .
C23.888.592.763.393.341 Hearing Loss .
C23.888.592.763.393.341.186 Deafness .
D03 Heterocyclic Compounds .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.759 Purines .
D03.633.100.759.590 Purine Nucleosides .
D03.633.100.759.590.138 Adenosine .
D03.633.100.759.590.138.025 Adenosine-5'-(N-ethylcarboxamide) .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.400 Neuropeptides .
D12.644.400.235 FMRFamide .
D12.776 Proteins .
D12.776.631 Nerve Tissue Proteins .
D12.776.631.650 Neuropeptides .
D12.776.631.650.235 FMRFamide .
D13 Nucleic Acids, Nucleotides, and Nucleosides .
D13.570 Nucleosides .
D13.570.583 Purine Nucleosides .
D13.570.583.138 Adenosine .
D13.570.583.138.025 Adenosine-5'-(N-ethylcarboxamide) .
D13.570.800 Ribonucleosides .
D13.570.800.096 Adenosine .
D13.570.800.096.250 Adenosine-5'-(N-ethylcarboxamide) .
E01 Diagnosis .
E01.370 Diagnostic Techniques and Procedures .
E01.370.225 Clinical Laboratory Techniques .
E01.370.225.625 Hematologic Tests .
E01.370.225.625.115 Blood Coagulation Tests .
E01.370.225.625.115.320 International Normalized Ratio .
E05 Investigative Techniques .
E05.200 Clinical Laboratory Techniques .
E05.200.625 Hematologic Tests .
E05.200.625.115 Blood Coagulation Tests .
E05.200.625.115.320 International Normalized Ratio .
M01 Persons .
M01.150 Disabled Persons .
M01.150.750 Persons With Hearing Impairments .
M01.526 Occupational Groups .
M01.526.799 Religious Personnel .
M01.526.799.500 Clergy .
 
 Terms
 Synonyms & Historicals		Documents
LILACS e MDL		 
Persons With Hearing Impairments .
Hearing Disabled Persons .
Deaf Person .
Disabled Persons, Hearing .
Hearing Disabled Person .
Hearing Impaired Person .
Person, Deaf .
Person, Hearing Disabled .
Person, Hearing Impaired .
Persons, Deaf .
Persons, Hearing Disabled .
Persons, Hearing Impaired .
Hard of Hearing Persons .
Hearing Impaired Persons .
Deaf Persons .
Deaf 21465 .
Persons with any degree of loss of hearing that has an impact on their activities of daily living or that requires special assistance or intervention. .
1.00
2141802
 
Adenosine-5'-(N-ethylcarboxamide) .
Adenosine-5'-N-ethyluronamide .
N6-Ethyl-carboxamido Adenosine .
5' N Ethylcarboxamidoadenosine .
Adenosine 5' N ethyluronamide .
Adenosine, N6-Ethyl-carboxamido .
N Ethylcarboxamidoadenosine .
N6 Ethyl carboxamido Adenosine .
N-Ethylcarboxamidoadenosine .
NECA 21419 .
5'-N-Ethylcarboxamidoadenosine .
A stable adenosine A1 and A2 receptor agonist. Experimentally, it inhibits cAMP and cGMP phosphodiesterase activity. .
0.41
01172
 
Deafness .
Bilateral Deafness .
Deaf Mutism .
Deaf-Mutism .
Deafness, Acquired .
Hearing Loss, Complete .
Hearing Loss, Extreme .
Acquired Deafness .
Complete Hearing Loss .
Deafness, Bilateral .
Deafness, Prelingual .
Extreme Hearing Loss .
Prelingual Deafness .
Deaf-Mutism .
DEAFNESS, SENSORINEURAL .
HEARING LOSS, EXTREME .
A general term for the complete loss of the ability to hear from both ears. .
0.41
70721528
 
Death .
Cardiac Death .
Determination of Death .
Death, Cardiac .
Near-Death Experience .
Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions. .
0.41
115612372
 
International Normalized Ratio .
International Normalized Ratios .
Normalized Ratio, International .
Normalized Ratios, International .
Ratio, International Normalized .
Ratios, International Normalized .
INR 21473 .
System established by the World Health Organization and the International Committee on Thrombosis and Hemostasis for monitoring and reporting blood coagulation tests. Under this system, results are standardized using the International Sensitivity Index for the particular test reagent/instrument combination used. .
0.38
404726
 
FMRFamide .
FMRF 21415 .
FMRF-NH2 .
FMRF-amide .
FMRFamide, (D-Arg)-Isomer .
FMRFamide, (D-Met)-Isomer .
FMRFamide, (D-Phe)-Isomer .
FMRFamide, (D-phenylalanine)-Isomer .
Phe-Met-Arg-Phe-NH2 .
Phe-Met-Arg-Phe-amide .
FMRF NH2 .
FMRF amide .
Phe Met Arg Phe amide .
A molluscan neuroactive peptide which induces a fast excitatory depolarizing response due to direct activation of amiloride-sensitive SODIUM CHANNELS. (From Nature 1995; 378(6558): 730-3) .
0.38
21061
 
Clergy .
Chaplains .
Clerics .
Deacons .
Imams .
Ministers .
Pastors .
Priests .
Rabbis .
Chaplain .
Cleric .
Deacon .
Imam 2347 .
Minister .
Pastor .
Priest .
Rabbi .
Persons ordained for religious duties, who serve as leaders and perform religious services. .
0.38
71912